Filing a DMF for Polychloroprene Elastomers with the U.S. FDA
Filing a drug master file (DMF) for Polychloroprene Elastomers can be a useful mechanism to market your
Polychloroprene Elastomers to the U.S. Drug Industry. Typical Polychloroprene Elastomers producers who have filed a DMF for
Polychloroprene Elastomers include:
-
Valois Sas
Registrar Corp can help you to properly prepare and submit your Polychloroprene Elastomers DMF to FDA.
As your Agent, Registrar Corp will perform the following administrative functions:
-
Format, assemble and deliver your Polychloroprene Elastomers DMF to FDA
-
Submit letters of authorization regarding your Polychloroprene Elastomers to FDA
-
Provide changes, additions and maintenance of your Polychloroprene Elastomers DMF
-
Respond to issues relating to ownership of your Polychloroprene Elastomers DMF
-
Assist with submission of responses to FDA concerning your Polychloroprene Elastomers DMF
-
Perform any required annual updates for your Polychloroprene Elastomers DMF
For more information about filing a DMF for Polychloroprene Elastomers, simply click below:
U.S. FDA Regulations:
U.S. FDA DMF Regulation: 21 C.F.R. Section 314.420
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
